Shenhao Liu, Chongsheng Qian, Haiping Dai, Lan Dai, Yanjun Wu, Zhen Yao, Zheng Li, Wenjie Gong, Aining Sun, Depei Wu, Shengli Xue. "Safety and efficacy of low-intensity chemotherapy combined with sequential blinatumomab and inotuzumab ozogamicin immunotherapy in newly diagnosed B-ALL patients unfit/fit-declined for intensive chemotherapy: A prospective, open-label, single-arm Phase II trial in progress." Blood, 2025. doi:10.1182/blood-2025-3358